Connect with us


Alcon Acquires Eyecare Firm

Tear Film Innovations manufactures the iLux Device.




FORT WORTH, TX – Alcon, a division of Novartis, has acquired Tear Film Innovations Inc., a privately held company and manufacturer of the iLux Device used to treat meibomian gland dysfunction, a leading cause of dry eye.

Financial terms of the deal were not disclosed.

The acquisition expands Alcon’s portfolio of ocular health products, including several treatments for the temporary relief of dry eye symptoms.

Using the iLux, a practitioner can warm the eyelids via disposable silicone pads to address blocked meibomian glands through the application of light-based heating.

“With the acquisition of Tear Film, we’re excited to bring this latest innovation to treat the millions of people around the world who suffer from dry eye,” said Andy Pawson, Alcon president and general manager, Global Vision Care Franchise. “Alcon remains committed to improving the lives of patients around the world through innovative technologies like the iLux Device to address significant unmet needs in eye care.”

The device received 510(k) clearance from the U.S. Food and Drug Administration in December 2017 and was officially launched by Tear Film in May 2018 at the annual meeting of the American Society for Cataract and Refractive Surgery.


The iLux is available in the U.S. and Canada. Alcon expects to announce plans to expand to other countries in 2019.

“Since launching the iLux Device earlier this year, we’ve seen an enthusiastic response from eye care professionals who have already begun to incorporate it as an advanced treatment option for patients suffering from Meibomian Gland Dysfunction,” said Rob Thornhill, CEO of Tear Film. “Now, as part of Alcon, we’re eager to bring this technology to even more offices throughout the world.”



The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.



Most Popular